Condition of the Gastrointestinal Tract in Rheumatological Patients

Сибиркина Марина Валерьевна

dc.contributor.author	Сибиркина Марина Валерьевна
dc.date.accessioned	2023-12-11T07:51:59Z
dc.date.available	2023-12-11T07:51:59Z
dc.date.issued	2023-12-11
dc.identifier.issn	2949-8848
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/9616
dc.description.abstract	In rheumatological practice, nonsteroidal anti-inflammatory drugs (NSAIDs) remain of great importance in the treatment of rheumatoid arthritis (RA), ankylosing spondylitis (AS), osteoarthrosis (OA), gout, etc., the widespread use of which is due to the relief of pain and inflammation, which are the main clinical manifestations of rheumatological diseases (RH). At the same time, it is reliably known that regular use of NSAIDs is associated with a number of side effects and risks, the leader of which is inflammatory, erosive, and ulcerative changes in the mucous membrane of the gastrointestinal tract (GIT) [13, 14]. One of the unresolved issues is the occurrence of secondary damage from the gastrointestinal tract (GI).	en_US
dc.language.iso	en_US	en_US
dc.relation.ispartofseries	Volume 02 Issue 11, November, 2023;
dc.subject	rheumatological diseases, gastrointestinal tract, NVPP, corticosteroids, apoptosis, proliferation, gastric mucosal epithelial cells.	en_US
dc.title	Condition of the Gastrointestinal Tract in Rheumatological Patients	en_US
dc.title.alternative	International Journal of Education, Social Science & Humanities. Finland Academic Research Science Publishers ISSN: 2945-4492 (online) \| (SJIF) = 7.502 Impact factor	en_US
dc.type	Article	en_US